Ifidancitinib Uses, Dosage, Side Effects and more
Ifidancitinib is under investigation in clinical trial NCT03585296 (A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis).
| Trade Name | Ifidancitinib |
| Generic | Ifidancitinib |
| Ifidancitinib Other Names | Ifidancitinib |
| Type | |
| Formula | C20H18FN5O3 |
| Weight | Average: 395.394 Monoisotopic: 395.139367623 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
